Psychedelic Compounds-Based Stocks Index Imploding

Our index of Psychedelic Compounds-Based Drug Stocks tracking clinical-stage startups still in R&D is down 60% YTD; it's -78% from its 2021 high.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.